Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Norfolk

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Vox Sanguinis|June 6, 2009
Massive transfusion--evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern EnglandA H Rose, A Kotzé, D Doolan, et al.
Surgical Endoscopy|April 1, 1996
Laparoscopic splenectomy. The suspended pedicle techniqueS P Dexter, I G Martin, D Alao, et al.
Acta Haematologica|January 1, 1983
Serum beta-2-microglobulin in disorders of myeloid proliferationD R Norfolk, J A Child, B E Roberts, et al.
British Journal of Rheumatology|March 1, 1993
The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisoloneR Kendall, A Wasti, A Harvey, et al.
Journal of Clinical Pathology|May 1, 1987
Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumoursR A Jones, C S Scott, D R Norfolk, et al.
Postgraduate Medical Journal|December 1, 1990
Pseudomonas maltophilia infections in neutropenic patients and the use of imipenemK G Kerr, P M Hawkey, J A Child, et al.
British Journal of Haematology|May 1, 1991
Thalidomide treatment for chronic graft-versus-host diseaseD Heney, D R Norfolk, J Wheeldon, et al.
Blood|July 1, 1995
Wider benefits of leukodepletion of blood productsJ A Copplestone, P Williamson, D R Norfolk, et al.
British Journal of Cancer|January 1, 1983
Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosisJ A Child, S M Crawford, D R Norfolk, et al.
Blood|June 17, 1998
Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cellsR J Johnson, A C Rawstron, S Richards, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Vox Sanguinis|June 6, 2009
Massive transfusion--evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern EnglandA H Rose, A Kotzé, D Doolan, et al.
Surgical Endoscopy|April 1, 1996
Laparoscopic splenectomy. The suspended pedicle techniqueS P Dexter, I G Martin, D Alao, et al.
Acta Haematologica|January 1, 1983
Serum beta-2-microglobulin in disorders of myeloid proliferationD R Norfolk, J A Child, B E Roberts, et al.
British Journal of Rheumatology|March 1, 1993
The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisoloneR Kendall, A Wasti, A Harvey, et al.
Journal of Clinical Pathology|May 1, 1987
Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumoursR A Jones, C S Scott, D R Norfolk, et al.
Postgraduate Medical Journal|December 1, 1990
Pseudomonas maltophilia infections in neutropenic patients and the use of imipenemK G Kerr, P M Hawkey, J A Child, et al.
British Journal of Haematology|May 1, 1991
Thalidomide treatment for chronic graft-versus-host diseaseD Heney, D R Norfolk, J Wheeldon, et al.
Blood|July 1, 1995
Wider benefits of leukodepletion of blood productsJ A Copplestone, P Williamson, D R Norfolk, et al.
British Journal of Cancer|January 1, 1983
Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosisJ A Child, S M Crawford, D R Norfolk, et al.
Blood|June 17, 1998
Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cellsR J Johnson, A C Rawstron, S Richards, et al.
Pageof 7